Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ruthenium Complex. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel visible-light driven Ru-catalyst enables room-temp alkyne-aldehyde addition. Reduces energy costs and simplifies supply chain for API synthesis.
Patent CN110105404A reveals a stable ruthenium catalyst enabling green imine synthesis. This technology offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104402934B reveals low-loading ruthenium catalysts for green quinoline synthesis, offering cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.